Abstract
We present the case of a 44-year-old man diagnosed with metastatic sarcomatoid carcinoma of the prostate. The pathogenesis and optimal treatment of this rare and aggressive subtype of prostate cancer are not fully clear. The patient was managed using a multimodality approach of chemotherapy, hormonal blockade and radiation therapy, with palliative intent.
MeSH terms
-
Adult
-
Biopsy
-
Carcinosarcoma / diagnosis*
-
Carcinosarcoma / pathology
-
Carcinosarcoma / secondary
-
Carcinosarcoma / therapy*
-
Combined Modality Therapy
-
Docetaxel / administration & dosage
-
Heart Neoplasms / secondary
-
Heart Ventricles
-
Humans
-
Magnetic Resonance Imaging
-
Male
-
Palliative Care
-
Pleural Effusion, Malignant / surgery
-
Prostatic Neoplasms / diagnosis*
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / therapy*
-
Radiotherapy
-
Thoracic Surgery, Video-Assisted
-
Tomography, X-Ray Computed